Translational Health Sciences

Study to examine how sleep during lockdown affects older people with or without dementia

4 May 2020

It has long been known that disrupted sleep can increase the risk of dementia and anecdotal evidence suggests COVID-19 anxiety is having a detrimental effect on sleep. A new UK-wide study led by academics at the University of Bristol will focus on how the current lockdown is affecting sleep in older people with and without dementia. It is hoped the findings will increase our understanding of how sleep can influence brain health and long-term dementia risk.

Dementia research and treatment boosted as unique collaboration announced

6 July 2016

Internationally renowned Professor Julian Hughes is announced as the first RICE Professor of Old Age Psychiatry in a collaboration between The Research Institute for the Care of Older People (RICE), the Royal United Hospitals Bath NHS Foundation Trust (RUH) and the University of Bristol.

Launch of Bristol Medical School marks new era for medical education

1 August 2017

The University of Bristol will launch the Bristol Medical School today [Tuesday 1 August]. This marks a new era for medical research and education in the West of England. Comprising around 1,330 students and 900 staff, the Bristol Medical School will provide a home for researchers, teachers and students, who through research and teaching will improve the health of individuals and populations locally, nationally and internationally.

Group B Streptococcus infection causes an estimated 150,000 preventable stillbirths and infant deaths every year

6 November 2017

An estimated one in five pregnant women around the world carry Group B Streptococcus (GBS) bacteria which is a major, yet preventable, cause of maternal and infant ill health globally.

Four Bristol scientists elected as new Fellows of the Royal Society

5 May 2017

Four University of Bristol academics have achieved the rare distinction of being elected Fellows of the world’s most eminent and oldest scientific academy in continuous existence, the Royal Society.

New international consortium to accelerate drug discovery in kidney diseases

6 November 2017

A new consortium to accelerate the discovery of novel drugs to treat kidney diseases is announced today [Monday 6 November]. The NEPLEX (nephron on a chip with cellular and extracellular matrix complexity) consortium, comprising leading academic institutions including the Universities of Bristol and Cambridge, and Evotec AG, will combine key technologies to develop and build a novel drug discovery device ("Nephron-on-a-Chip").

Clinical trial discovers new way to prevent children with arthritis and eye disease losing their sight

5 May 2017

A new drug combination that could help thousands of children with arthritis and prevent them from serious complications, including blindness, has been discovered by researchers and thanks to a trial funded by Arthritis Research UK and the National Institute for Health Research (NIHR).

Researchers to develop ‘wearable’ robotic tools for surgery

14 March 2017

A collaborative team of researchers is to develop a wearable robotic system for minimally invasive surgery, also known as keyhole surgery, that will offer surgeons natural and dexterous movement as well as the ability to ‘sense’, ‘see’, control and safely navigate through the surgical environment.

Researchers reveal all at Bristol 3MT finals

4 June 2015

Ever wondered what kind of research postgraduate students are working on at Bristol? Find out when eight take to the stage next Wednesday (10 June) to present their 80,000-word theses in just three minutes.

Post-mortem assessment guidelines for vascular cognitive impairment

5 September 2016

New research, led by academics at the University of Bristol, has outlined the first validated set of pathological criteria for assessing the likelihood that cognitive impairment was caused by vascular disease.